Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD22: an inhibitory enigma.

Jennifer A Walker1, Kenneth G C Smith

  • 1Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Addenbrooke's Hospital, Cambridge CB2 0XY, United Kingdom. jw425@cam.ac.uk

Immunology
|December 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Care Unit Room Characteristics and Association with the Development of Delirium.

NeuroSci·2026
Same author

Routine chest X-ray in atraumatic chest pain with normal vital signs: A propensity-matched TriNetX analysis.

The American journal of emergency medicine·2026
Same author

The authors respond to reader comment regarding Outcomes of boarding critically ill patients in U.S. EDs: A systematic review and meta-analysis.

The American journal of emergency medicine·2026
Same author

Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals.

Science (New York, N.Y.)·2025
Same author

Predicting Blood Pressure and Blood Pressure Variability in Spontaneous Intracerebral Hemorrhage in the Emergency Department Using Machine Learning.

Journal of clinical medicine·2025
Same author

Outcomes of boarding critically ill patients in U.S. EDs: A systematic review and meta-analysis.

The American journal of emergency medicine·2025
Same journal

Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease.

Immunology·2026
Same journal

Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders.

Immunology·2026
Same journal

Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation.

Immunology·2026
Same journal

Senescent Human Liver Endothelial Cells Mediate CD4<sup>+</sup> T Cell Recruitment via ICOSL.

Immunology·2026
Same journal

The Transcription Factor EGR2 Plays a Central Role in the Expansion and Function of TCRαβ<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> Double Negative T Cells in lpr Lupus Mice.

Immunology·2026
Same journal

Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.

Immunology·2026
See all related articles

CD22, a B-cell receptor coreceptor, regulates B-cell activation thresholds. Recent studies present conflicting models for how CD22 ligand binding controls its function, impacting autoimmune disease research.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • CD22 functions as an inhibitory coreceptor for the B-cell receptor (BCR).
  • CD22's modulation of B-cell signaling is dependent on its proximity to the BCR.
  • Ligand binding, specifically to alpha2,6-linked sialic acids, governs CD22 proximity to the BCR.

Purpose of the Study:

  • To reconcile conflicting models of CD22 function based on ligand binding.
  • To explore the role of CD22 defects in autoimmune disease.
  • To discuss the influence of genetic background on CD22 function and autoimmunity.

Main Methods:

  • Review and analysis of recent experimental studies on CD22.
  • Discussion of in vivo mechanisms controlling CD22 function.

Related Experiment Videos

  • Examination of evidence linking CD22 defects to autoimmune conditions.
  • Main Results:

    • Recent studies present two seemingly mutually exclusive models for CD22 ligand binding: one promoting function, the other inhibiting it.
    • The precise in vivo mechanisms by which ligand binding regulates CD22 remain incompletely understood.
    • Evidence suggests a link between CD22 dysfunction and autoimmune disease, modulated by genetic factors.

    Conclusions:

    • Reconciliation of conflicting CD22 models is necessary for a complete understanding of its in vivo function.
    • Further research is needed to elucidate the precise role of CD22 in B-cell signaling and autoimmunity.
    • Genetic background significantly influences CD22 function and susceptibility to autoimmune diseases.